▲
Symbiotec Pharmalab surges after Pithampur facility gets EIR from US FDA
- Symbiotec Pharmalab rose 5.56% to Rs 1115.50 after its Pithampur facility received a US FDA EIR
- US FDA clearance strengthens Symbiotec Pharmalab’s regulatory standing; relevant to Indian pharma investors
